How Does Ozempic Help Prevent Heart Attack?

Ozempic contains semaglutide, a medication in a class called GLP-1 receptor agonists. Research has found cardiovascular benefits from semaglutide in certain groups of people. Ozempic is approved to reduce the combined risk of cardiovascular death, nonfatal heart attack, and nonfatal stroke in adults with type 2 diabetes and established cardiovascular disease.

That doesn’t mean Ozempic should be started by anyone who wants to prevent a heart attack. Whether it makes sense for you depends on your diabetes status, cardiovascular risk, medical history, current medications, and other factors your doctor will consider. This guide explains what the research shows, how Ozempic differs from Wegovy, and what to discuss with your doctor.

This content is for informational purposes only. Never start, stop, or change Ozempic, Wegovy, or any other GLP-1 medication based on this article without speaking to your doctor first.

What Does Ozempic Do to the Heart?

Semaglutide may affect cardiovascular health through several pathways working together. These include:

• Improving blood sugar control
• Often reducing body weight during treatment, although Ozempic isn’t approved specifically for weight management
• Improving cardiovascular risk factors such as blood pressure and cholesterol in some people
• Possibly affecting inflammation, blood vessel function, and other processes tied to cardiovascular disease
• Reducing the combined risk of major adverse cardiovascular events in specific populations studied in clinical trials

It’s more accurate to think of this as a broader metabolic and cardiovascular effect. Ozempic doesn’t simply strengthen the heart muscle itself.

Does Ozempic Help Prevent Heart Attacks?

Ozempic is approved to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. This combined outcome includes cardiovascular death, nonfatal heart attack, and nonfatal stroke.

It wouldn’t be accurate to say Ozempic completely prevents heart attacks. The evidence shows that it can lower the combined risk of major cardiovascular events in certain groups. Individual results may differ, and the benefit shouldn’t be assumed to apply to everyone taking the medication.

Important evidence to know:

The SUSTAIN-6 cardiovascular outcomes trial studied injectable semaglutide in people with type 2 diabetes and high cardiovascular risk. The trial found a 26% relative reduction in the combined risk of cardiovascular death, nonfatal heart attack, or nonfatal stroke. When the outcomes were considered separately, the reduction in nonfatal stroke was statistically significant. Nonfatal heart attacks occurred less often with semaglutide, but that individual difference wasn’t statistically significant.

The SELECT trial studied semaglutide at the dose used for Wegovy in adults with overweight or obesity and established cardiovascular disease who didn’t have diabetes. It found a 20% relative reduction in the combined risk of cardiovascular death, nonfatal heart attack, or nonfatal stroke.

These trials studied different doses and populations. Their results shouldn’t be treated as though Ozempic and Wegovy are interchangeable.

How Does Ozempic Help Your Heart?

The cardiovascular benefits linked to semaglutide likely come from several effects working together.

Better blood sugar control

Poorly controlled diabetes raises cardiovascular risk over time. Improving blood sugar control can help address one important part of that risk.

Weight reduction

Excess weight is linked to high blood pressure, unhealthy cholesterol levels, diabetes, and greater cardiovascular risk. Weight loss during semaglutide treatment may contribute to some of its cardiovascular benefits.

Effects on cardiovascular risk factors

Semaglutide has been associated with improvements in blood pressure, cholesterol, and other metabolic markers. These changes may help lower long-term cardiovascular risk.

Possible direct cardiovascular effects

Researchers are studying whether GLP-1 receptor agonists affect inflammation, blood vessels, and cardiovascular function through pathways that are separate from weight loss. Some benefits appeared before participants reached their maximum weight loss, suggesting that weight loss may not be the only factor involved. However, these possible mechanisms are still being studied.

What Are the Cardiovascular Benefits of Wegovy?

Wegovy also contains semaglutide, but it has different dosing and approved uses than Ozempic.

The SELECT trial studied semaglutide in adults with overweight or obesity and established cardiovascular disease who didn’t have diabetes. The trial found a 20% relative reduction in the combined risk of cardiovascular death, nonfatal heart attack, or nonfatal stroke.

Based on this research, the FDA approved Wegovy to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity. Wegovy is also approved for chronic weight management in eligible patients.

Ozempic is approved for adults with type 2 diabetes, including cardiovascular risk reduction in those with established cardiovascular disease. The two medications contain the same active ingredient, but they shouldn’t be treated as interchangeable.

Is Ozempic Good for Heart Health?

The honest answer depends on the person taking it. Evidence supports cardiovascular benefits from Ozempic in higher-risk adults with type 2 diabetes, particularly those with established cardiovascular disease.

Ozempic isn’t appropriate for everyone. Someone without type 2 diabetes shouldn’t assume Ozempic is the right medication simply because cardiovascular benefits have been documented in specific groups. The decision requires a review of your full medical history, current medications, and personal risk factors.

Does Ozempic Cause Heart Problems?

Cardiovascular outcomes research has generally found a benefit rather than an increased risk of major cardiovascular events in the populations studied. However, Ozempic can cause side effects that require attention.

Nausea, diarrhea, and vomiting can lead to dehydration and, in some cases, kidney problems. Ozempic can also cause a small increase in resting heart rate. Talk with your doctor if you experience ongoing vomiting, diarrhea, dehydration, palpitations, or a noticeable change in your resting heart rate.

Call emergency medical services if you develop chest pressure, trouble breathing, fainting, or other symptoms that may signal a medical emergency.

Does Ozempic Increase Heart Rate?

GLP-1 receptor agonists, including semaglutide, can cause a modest increase in resting heart rate in some people. A higher heart rate on its own does not necessarily mean the medication is harming your heart, but it is still worth monitoring.

If you notice palpitations or a heart rate change that concerns you, bring this up with your healthcare provider rather than assuming it is expected or ignoring it.

Ozempic and Heart Failure: What Does the Research Show?

Heart failure and heart attack are different conditions, so it’s important to keep them separate when reviewing semaglutide research.

Research involving semaglutide at the higher dose used for Wegovy has found benefits in certain people with obesity-related heart failure with preserved ejection fraction, often called HFpEF. Participants experienced improvements in symptoms, physical limitations, exercise ability, and body weight.

A separate analysis of the SELECT trial also found cardiovascular benefits among participants who already had heart failure. However, these findings don’t mean Ozempic is approved as a general treatment for every type of heart failure.

If you have heart failure, talk with your cardiologist before taking semaglutide. The possible benefits and risks depend on your type of heart failure, weight, diabetes status, kidney function, medications, and overall health.

Can Ozempic Reduce the Risk of Stroke?

Stroke is tracked as one of the major cardiovascular events in semaglutide research, but the evidence here is more mixed than it is for heart attack and cardiovascular death. Some pooled analyses of trial data have not found a statistically significant reduction in nonfatal stroke specifically, even while showing benefit for the broader combined outcome of major cardiovascular events.

The overall cardiovascular effect depends heavily on the population studied and the medication’s approved indication, which is part of why individual outcomes like stroke risk reduction should not be assumed to apply universally.

Ozempic vs Wegovy for Heart Health

Both medications contain the same active ingredient but differ in dose and approved use.

These medications shouldn’t be substituted for one another without medical guidance. Approved formulations, doses, and uses can change, so confirm current information with your doctor or pharmacist.

Who May Benefit From Semaglutide for Cardiovascular Risk?

Cardiovascular benefit may be relevant to certain adults who fall within a current approved indication, including:

• Adults with type 2 diabetes and established cardiovascular disease who may qualify for Ozempic
• Adults with established cardiovascular disease and either overweight or obesity who may qualify for Wegovy
• Adults with type 2 diabetes and chronic kidney disease who may qualify for Ozempic to reduce certain kidney outcomes and cardiovascular death

A healthcare provider must decide whether semaglutide is appropriate after reviewing your medical history, current medications, and personal risks.

Who Should Not Take Ozempic Without Medical Advice?

Ozempic is a prescription medication and shouldn’t be taken without medical guidance. According to current prescribing information, Ozempic shouldn’t be used by people with:

• A personal or family history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2
• A previous serious allergic reaction to semaglutide or an ingredient in Ozempic

Other situations require careful discussion with a healthcare provider before treatment, including:

• A history of pancreatitis
• Diabetic retinopathy
• Severe gastroparesis or other serious digestive problems
• Kidney problems or a higher risk of dehydration
• Gallbladder problems
• Use of insulin or a sulfonylurea, which may raise the risk of low blood sugar
• Pregnancy, breastfeeding, or plans to become pregnant
• An upcoming procedure involving anesthesia or deep sedation

Current prescribing information recommends stopping Ozempic at least two months before a planned pregnancy. Don’t stop it on your own. Talk with your healthcare provider about your treatment and blood sugar plan.

How to Protect Your Heart While Taking Ozempic

Medication should complement, not replace, heart healthy habits. Alongside prescribed treatment, it still matters to:

• Eat a balanced, heart healthy diet, covered further in our anti inflammatory nutrition guide
• Exercise regularly
• Avoid smoking, discussed in our nicotine and heart risk guide
• Manage blood pressure, covered in our hypertension guide
• Manage cholesterol, covered in our cholesterol management guide
• Manage blood sugar, especially relevant given the connection between insulin resistance and metabolic syndrome
• Get adequate sleep
• Maintain a healthy weight through sustainable habits, discussed in our obesity and cardiovascular risk guide
• Take all prescribed medications correctly and consistently
• Attend regular medical checkups and cardiovascular screening

Semaglutide may provide cardiovascular benefits for certain people, but it should be one part of a complete heart attack prevention plan, not a stand-alone solution.

Frequently Asked Questions

What does Ozempic do to your heart? 

Ozempic may improve blood sugar, body weight, blood pressure, and cholesterol. It has also been shown to reduce the combined risk of cardiovascular death, nonfatal heart attack, and nonfatal stroke in adults with type 2 diabetes and established cardiovascular disease.

Is Ozempic good for your heart? 

Ozempic has documented cardiovascular benefits for certain adults with type 2 diabetes and established cardiovascular disease. Whether it is appropriate for you depends on your medical history and personal risk factors.

Does Ozempic prevent heart attacks? 

It has not been shown to completely prevent heart attacks. The evidence shows a reduced risk of major cardiovascular events, including nonfatal heart attack, in certain populations studied in clinical trials.

Does Ozempic reduce the risk of heart attack and stroke? 

Research has shown a reduction in nonfatal heart attack and cardiovascular death in pooled trial data, though the evidence for stroke reduction specifically has been less consistent across studies.

Does Ozempic cause heart problems? 

Available evidence has generally shown cardiovascular benefit rather than increased risk of major cardiovascular events, though side effects and heart rate changes are worth discussing with your doctor.

Does Ozempic increase heart rate? 

Yes, a modest increase in resting heart rate has been observed in some people taking GLP-1 medications. This does not necessarily indicate harm, but should be monitored with your healthcare provider.

Is Wegovy good for heart health? 

The SELECT trial found that Wegovy reduced major cardiovascular events in adults with overweight or obesity and established cardiovascular disease who did not have diabetes.

What are the cardiovascular benefits of Wegovy? 

Research has linked Wegovy to a reduced risk of major cardiovascular events, including cardiovascular death and nonfatal heart attack, in the specific population studied.

Can Ozempic help with heart failure? 

Research using semaglutide at the dose associated with Wegovy has found improvements in symptoms and physical function among certain people with obesity-related heart failure with preserved ejection fraction. Ozempic isn’t approved as a general treatment for all forms of heart failure.

What is the difference between Ozempic and Wegovy for heart health? 

Both contain semaglutide, but they have different approved uses and dosing. Ozempic is approved to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Wegovy is approved for the same combined cardiovascular outcome in adults with established cardiovascular disease and either overweight or obesity.

Can you take Ozempic if you have heart disease? 

Some adults with type 2 diabetes and established cardiovascular disease may qualify for Ozempic specifically because of its cardiovascular indication. Your doctor must still review your medical history, current medications, and possible risks before prescribing it.

Does Ozempic reduce cardiovascular risk in people without diabetes? 

Ozempic’s cardiovascular indication applies to adults with type 2 diabetes and established cardiovascular disease. The main clinical trial evidence involving semaglutide in people without diabetes came from the SELECT trial, which used the dose and product associated with Wegovy.

Final Takeaway

Semaglutide may provide cardiovascular benefits for certain people, particularly adults with type 2 diabetes and established cardiovascular disease or adults with cardiovascular disease and overweight or obesity. However, Ozempic and Wegovy have different approved uses and shouldn’t be treated as interchangeable.

If you’re wondering whether either medication fits your cardiovascular risk profile, talk with your doctor. They can review your medical history, current medications, and the latest evidence before recommending treatment.